logo
ProjectArchived

DOD Tuberous Sclerosis Complex Idea Development Award

Sector: Manufacturing (Industrial) • Location: United States of America

Source: Grants.gov

The Tuberous Sclerosis Complex Research Program (TSCRP) was established in 2002 to promote innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC). The mission of the TSCRP is to encourage innovative research aimed at understanding the pathogenesis of TSC and to translate these findings to the care of individuals with TSC. The FY11 TSCRP Idea Development

Status
Closed
Sector
Manufacturing (Industrial), Education, Hospital, Aerospace & Defense, Government, Hotel
Location
United States of America
Updated
22 Jul 2026
Source
Grants.gov

ConstructChat

Ask ConstructChat about DOD Tuberous Sclerosis Complex Idea Development Award

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

5 Q
The project “DOD Tuberous Sclerosis Complex Idea Development Award” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Participants

Sponsoring Agency

Status

Original status

archived

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

The Tuberous Sclerosis Complex Research Program (TSCRP) was established in 2002 to promote innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC). The mission of the TSCRP is to encourage innovative research aimed at understanding the pathogenesis of TSC and to translate these findings to the care of individuals with TSC. The FY11 TSCRP Idea Development Award supports high-impact, innovative research that will drive the field of TSC research forward. Preclinical studies are encouraged but clinical trials are not allowed. Important aspects of the Idea Development Award are as follows: The proposed research should have a significant impact on the concepts or methods that drive the field of TSC research. The proposed research is expected to make an important and original contribution to advancing TSC research and/or patient care. Research deemed innovative may represent a new paradigm, challenge existing paradigms, or look at existing problems from new perspectives or exhibit other uniquely creative qualities. Research may be innovative in study concept, research methods or technology, clinical interventions, or adaptations of existing methods or technologies. Research that represents an incremental advance on previously published work is not considered innovative. Preliminary data should be included that is relevant to the proposed project. The FY11 TSCRP strongly supports collaborative research between basic scientists and clinical researchers, and between academic scientists and biotechnology/pharmaceutical industry scientists. Collaborations that bring new perspectives from other disciplines or bring new investigators into the TSC field are also strongly encouraged.

Budget

Location

Country

United States of America (USA)

Source

Source reliability

High

Source

Grants.gov

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial), Education, Hospital, Aerospace & Defense, Government, Hotel

Article published date

2023-06-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project